Meneray M A, Fields T Y, Bennett D J
Department of Physiology, Louisiana State University Medical Center, New Orleans 70119, USA.
Cornea. 2000 Jan;19(1):92-8. doi: 10.1097/00003226-200001000-00018.
To determine whether G-protein-mediated inhibition of secretion by met-enkephalin involves cyclic adenosine monophosphate (cAMP)-dependent events and to identify the G proteins that couple met-enkephalin to inhibition of lacrimal secretion.
Secretion of protein was measured in 3-day primary cultures of rabbit lacrimal acini exposed to vehicle, the cholinergic agonist carbachol (Cch), the beta-adrenergic agonist isoproterenol (Isop), vasoactive intestinal peptide (VIP), or forskolin (FSK) with or without the enkephalin analog D-ala2-met-enkephalinamide (DALA). In separate experiments, cells were pretreated with pertussis toxin or polyclonal antibodies against the alpha subunits of Gi/Go to determine the physiologic role of G proteins in met-enkephalin inhibition of the release of lacrimal protein. Adenylyl cyclase (AC) activity was measured by a cAMP-dependent protein kinase binding assay in lacrimal membranes in response to the same agonists used in the secretion studies.
Cch resulted in a significant increase in protein release from cultured lacrimal acini. Increased secretion also occurred with Isop, VIP, and FSK. Cch- and Isop-stimulated secretion was inhibited by DALA to near-basal values. However, DALA did not inhibit VIP- or FSK-stimulated secretion. The inhibitory effect of DALA on Cch and Isop stimulation of secretion was reversed by pertussis toxin. Inhibition of Cch-stimulated secretion was blocked by antibody specific to a common peptide sequence of Gialpha1 and Gialpha2 but was not blocked by anti-Gialpha1 antibody. The inhibitory effect on Cch-stimulated secretion was also blocked by anti-Gialpha3 and anti-Goalpha. Similar experiments resulted in a reversal of DALA inhibition of beta-adrenergic stimulation of secretion by immunoneutralization of Gialpha1/2 and Goalpha but not by immunoneutralization of Gialpha1 or Gialpha3. VIP, Isop, and FSK significantly stimulated AC. However, Cch had no effect on the activity of the enzyme. In addition, DALA had no effect on AC activity under any conditions.
These results show that enkephalin inhibition of cholinergic and beta-adrenergic stimulation of secretion is mediated by Gi2, Gi3, and Go. The effector coupled by the G proteins is not AC. However, we suggest a role for met-enkephalin in G-protein-coupled modulation of ion channels important for cholinergic and beta-adrenergic stimulation of lacrimal secretion.
确定G蛋白介导的甲硫氨酸脑啡肽对分泌的抑制作用是否涉及环磷酸腺苷(cAMP)依赖性事件,并鉴定将甲硫氨酸脑啡肽与泪液分泌抑制相偶联的G蛋白。
在兔泪腺腺泡3天的原代培养物中测量蛋白质分泌,这些培养物暴露于溶剂、胆碱能激动剂卡巴胆碱(Cch)、β-肾上腺素能激动剂异丙肾上腺素(Isop)、血管活性肠肽(VIP)或福斯可林(FSK),同时加入或不加入脑啡肽类似物D-丙氨酸2-甲硫氨酸脑啡肽酰胺(DALA)。在单独的实验中,细胞用百日咳毒素或针对Gi/Goα亚基的多克隆抗体进行预处理,以确定G蛋白在甲硫氨酸脑啡肽抑制泪液蛋白释放中的生理作用。通过cAMP依赖性蛋白激酶结合测定法测量泪腺膜中腺苷酸环化酶(AC)的活性,以响应分泌研究中使用的相同激动剂。
Cch导致培养的泪腺腺泡中蛋白质释放显著增加。Isop、VIP和FSK也导致分泌增加。DALA将Cch和Isop刺激的分泌抑制至接近基础值。然而,DALA并未抑制VIP或FSK刺激的分泌。百日咳毒素可逆转DALA对Cch和Isop刺激分泌的抑制作用。针对Gialpha1和Gialpha2共同肽序列的特异性抗体可阻断对Cch刺激分泌的抑制作用,但抗Gialpha1抗体则不能。抗Gialpha3和抗Goalpha也可阻断对Cch刺激分泌的抑制作用。类似的实验通过对Gialpha1/2和Goalpha进行免疫中和,逆转了DALA对β-肾上腺素能刺激分泌的抑制作用,但对Gialpha1或Gialpha3进行免疫中和则无效*。VIP、Isop和FSK显著刺激AC。然而,Cch对该酶的活性没有影响。此外,在任何条件下DALA对AC活性均无影响。
这些结果表明,脑啡肽对胆碱能和β-肾上腺素能刺激分泌的抑制作用是由Gi2、Gi3和Go介导的。G蛋白偶联的效应器不是AC。然而,我们认为甲硫氨酸脑啡肽在G蛋白偶联的离子通道调节中起作用,这些离子通道对胆碱能和β-肾上腺素能刺激泪液分泌很重要。